Literature DB >> 1714041

Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs.

P A Johnston1, L A Chahl.   

Abstract

This study was an investigation of the effects of the tachykinin antagonists, spantide and (D-Pro4, D-Trp7,9,10)substance P 4-11, injected intracerebroventricularly (ICV), on the locomotor and behavioural responses of guinea-pigs to substance P (SP) injected ICV and to naloxone-induced morphine withdrawal. SP, 50 nmol, produced increased locomotor activity and behaviour that mimicked the response induced by injection of naloxone hydrochloride, 15 mg/kg, in guinea-pigs treated 2 h previously with morphine sulphate, 15 mg/kg. Spantide or (D-Pro4, D-Trp7,9,10)SP4-11, 10 nmol, reduced the locomotor and behavioural responses to SP and to morphine withdrawal. The results support the suggestion that SP or a related tachykinin might be a mediator of the opioid withdrawal response in the central nervous system as has been proposed for the enteric nervous system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714041     DOI: 10.1007/bf00251127

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  32 in total

1.  Increased spontaneous activity following substance P infusion into A10 dopaminergic area.

Authors:  L Stinus; A E Kelley; S D Iversen
Journal:  Nature       Date:  1978-12-07       Impact factor: 49.962

2.  Behavioural effects of tachykinins and related peptides.

Authors:  P J Elliott; S D Iversen
Journal:  Brain Res       Date:  1986-08-27       Impact factor: 3.252

3.  Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.

Authors:  I Christensson-Nylander; M Herrera-Marschitz; W Staines; T Hökfelt; L Terenius; U Ungerstedt; C Cuello; W H Oertel; M Goldstein
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

4.  Increased plasma catecholamines and locomotor activity induced by centrally administered substance P in guinea-pigs.

Authors:  P J Brent; P A Johnston; L A Chahl
Journal:  Neuropharmacology       Date:  1988-07       Impact factor: 5.250

5.  Evidence that physical dependence on morphine is mediated by the ventral midbrain.

Authors:  A A Baumeister; T G Anticich; G Hebert; M F Hawkins; M Nagy
Journal:  Neuropharmacology       Date:  1989-11       Impact factor: 5.250

6.  Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.

Authors:  P Baruch; F Artaud; G Godeheu; L Barbeito; J Glowinski; A Chéramy
Journal:  Neuroscience       Date:  1988-06       Impact factor: 3.590

7.  Effect of a tachykinin antagonist on a nociceptive reflex in the isolated spinal cord-tail preparation of the newborn rat.

Authors:  M Otsuka; M Yanagisawa
Journal:  J Physiol       Date:  1988-01       Impact factor: 5.182

8.  Withdrawal responses of guinea-pig isolated ileum following brief exposure to opiates and opioid peptides.

Authors:  L A Chahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

9.  Effect of the substance P antagonist spantide on adrenal sympathetic nerve activity in rats.

Authors:  H Togashi; M Yoshioka; M Minami; K Shimamura; H Saito; C Kitada; M Fujino
Journal:  Jpn J Pharmacol       Date:  1987-03

10.  Behavioural activation induced in the rat by substance P infusion into ventral tegmental area: implication of dopaminergic A10 neurones.

Authors:  A E Kelley; L Stinus; S D Iversen
Journal:  Neurosci Lett       Date:  1979-03       Impact factor: 3.046

View more
  9 in total

1.  Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists.

Authors:  K J Powell; W Ma; M Sutak; H Doods; R Quirion; K Jhamandas
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

2.  Increased morphine analgesia and reduced side effects in mice lacking the tac1 gene.

Authors:  A Bilkei-Gorzo; J Berner; J Zimmermann; R Wickström; I Racz; A Zimmer
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.

Authors:  P J Brent
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  The role of spinal neuropeptides and prostaglandins in opioid physical dependence.

Authors:  Tuan Trang; Maaja Sutak; Remi Quirion; Khem Jhamandas
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

5.  Morphine, D-Pen2, D-Pen5 enkephalin and U50,488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs.

Authors:  P J Brent; G Bot
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Naloxone-reversible effect of spantide on the spinally mediated behavioural response induced by neurokinin-2 and -3 receptor agonists.

Authors:  T Sakurada; Y Manome; K Katsumata; H Uchiumi; K Tan-No; S Sakurada; K Kisara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

7.  Expression of mu opioid receptor in dorsal diencephalic conduction system: new insights for the medial habenula.

Authors:  O Gardon; L Faget; P Chu Sin Chung; A Matifas; D Massotte; B L Kieffer
Journal:  Neuroscience       Date:  2014-07-31       Impact factor: 3.590

8.  Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.

Authors:  O Piot; J Betschart; I Grall; S Ravard; C Garret; J C Blanchard
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

9.  Long-term Morphine-treated Rats are more Sensitive to Antinociceptive Effect of Diclofenac than the Morphine-naive rats.

Authors:  Esmaeil Akbari; Ebrahim Mirzaei; Naghi Shahabi Majd
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.